首页> 外文期刊>Journal of Coordination Chemistry >A comparative study on the interaction with calf thymus DNA of a Ni(II) complex of the anticancer drug adriamycin and a Ni(II) complex of sodium 1,4-dihydroxy-9,10-anthraquinone-2-sulphonate
【24h】

A comparative study on the interaction with calf thymus DNA of a Ni(II) complex of the anticancer drug adriamycin and a Ni(II) complex of sodium 1,4-dihydroxy-9,10-anthraquinone-2-sulphonate

机译:抗癌药物阿霉素的Ni(II)配合物与1,4-二羟基-9,10-蒽醌-2-磺酸钠的Ni(II)配合物与小牛胸腺DNA相互作用的比较研究

获取原文
获取原文并翻译 | 示例
           

摘要

The anthracycline drug adriamycin and its metal complexes are efficient in treating several forms of human cancers with recognized antineoplastic activity attributed to strong interactions with DNA within the target cells. The hydroxy-9,10-anthraquinone unit present in the molecule controls and regulates drug action. Metal ions when linked to adriamycin help to reduce the generation of radicals responsible for toxic side effects. A complex of adriamycin with Ni(II) was prepared and its physicochemical characteristics and DNA-binding ability were compared to a Ni(II) complex of sodium-1,4-dihydroxy-9,10-anthraquinone-2-sulphonate (NaLH2), an analog of adriamycin. Interactions with calf thymus DNA of both complexes were studied by UV-Vis and fluorescence spectroscopy. Binding parameters determined for both complexes agree with each other. Binding of the Ni(II)-adriamycin complex to DNA was five to eight times stronger than for the Ni(II) complex of the hydroxy-9,10-anthraquinone analog, Na2[Ni(NaLH)2Cl2] · 2H2O, i.e., Ni(NaLH)2. The difference in binding was attributed to the presence of sugar units in adriamycin and to its absence in NaLH2. Although the Ni(II) complex of the hydroxy-9,10-anthraquinone analog of adriamycin [Ni(NaLH)2] was slightly weaker in binding DNA than the drug and its Ni(II) complex, a much lower cost of the former justifies its consideration as a substitute for the anthracycline drugs that are now in use.View full textDownload full textKeywordsAdriamycin, Ni(II), Ni(NaLH)2 , Calf thymus DNA, Binding parametersRelated var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; Add to shortlist Link Permalink http://dx.doi.org/10.1080/00958972.2012.659730
机译:蒽环类药物阿霉素及其金属络合物可有效治疗多种形式的人类癌症,这种癌症具有公认的抗肿瘤活性,这归因于与靶细胞内DNA的强相互作用。分子中存在的羟基-9,10-蒽醌单元控制和调节药物作用。与阿霉素连接的金属离子有助于减少产生毒副作用的自由基。制备了阿霉素与Ni(II)的复合物,并将其理化特性和DNA结合能力与1,4-二羟基-9,10-蒽醌-2-磺酸钠(NaLH < sub> 2 ),是阿霉素的类似物。通过紫外-可见光谱和荧光光谱研究了两种复合物与小牛胸腺DNA的相互作用。为两种复合物确定的结合参数彼此一致。 Ni(II)-阿霉素复合物与DNA的结合比羟基-9,10-蒽醌类似物Na 2 [Ni(NaLHH ) 2 Cl 2 ]··2H 2 O,即Ni(NaLH) 2 。结合的差异归因于阿霉素中糖单元的存在以及NaLH 2 中不存在糖单元。尽管阿霉素[Ni(NaLH) 2 ]羟基-9,10-蒽醌类似物的Ni(II)配合物比药物及其Ni(II)配合物的结合DNA稍弱,前者的成本要低得多,因此可以考虑取代目前正在使用的蒽环类药物。查看全文下载全文关键词阿霉素,Ni(II),Ni(NaLH)2,小牛胸腺DNA,结合参数相关var addthis_config = { ui_cobrand:“ Taylor&Francis Online”,servicescompact:“ citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,更多”,发布:“ ra-4dff56cd6bb1830b”};添加到候选列表链接永久链接http://dx.doi.org/10.1080/00958972.2012.659730

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号